The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.

Saved in:
Bibliographic Details
Title: The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
Authors: Schilter H; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Findlay AD; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Perryman L; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Yow TT; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Moses J; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Zahoor A; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Turner CI; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Deodhar M; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Foot JS; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Zhou W; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Greco A; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Joshi A; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Rayner B; Heart Research Institute, Sydney, NSW, Australia.; Sydney Medical School, University of Sydney, Sydney, NSW, Australia., Townsend S; Centre for Liver Research, Institute of Immunology, National Institute for Health Research Liver Biomedical Research Unit, University Hospitals, Birmingham, UK.; Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, UK., Buson A; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia., Jarolimek W; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.
Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2019 Mar; Vol. 23 (3), pp. 1759-1770. Date of Electronic Publication: 2018 Dec 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30536539
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schilter+H%22">Schilter H</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Findlay+AD%22">Findlay AD</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Perryman+L%22">Perryman L</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Yow+TT%22">Yow TT</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Moses+J%22">Moses J</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Zahoor+A%22">Zahoor A</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Turner+CI%22">Turner CI</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Deodhar+M%22">Deodhar M</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Foot+JS%22">Foot JS</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Zhou+W%22">Zhou W</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Greco+A%22">Greco A</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Joshi+A%22">Joshi A</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Rayner+B%22">Rayner B</searchLink>; Heart Research Institute, Sydney, NSW, Australia.; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Townsend+S%22">Townsend S</searchLink>; Centre for Liver Research, Institute of Immunology, National Institute for Health Research Liver Biomedical Research Unit, University Hospitals, Birmingham, UK.; Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Buson+A%22">Buson A</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Jarolimek+W%22">Jarolimek W</searchLink>; Drug Discovery department, Pharmaxis Ltd., Sydney, NSW, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101083777%22">Journal of cellular and molecular medicine</searchLink> [J Cell Mol Med] 2019 Mar; Vol. 23 (3), pp. 1759-1770. <i>Date of Electronic Publication: </i>2018 Dec 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101083777 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1582-4934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215821838%22">15821838 </searchLink><i>NLM ISO Abbreviation: </i>J Cell Mol Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30536539
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jcmm.14074
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1759
    Titles:
      – TitleFull: The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schilter H
      – PersonEntity:
          Name:
            NameFull: Findlay AD
      – PersonEntity:
          Name:
            NameFull: Perryman L
      – PersonEntity:
          Name:
            NameFull: Yow TT
      – PersonEntity:
          Name:
            NameFull: Moses J
      – PersonEntity:
          Name:
            NameFull: Zahoor A
      – PersonEntity:
          Name:
            NameFull: Turner CI
      – PersonEntity:
          Name:
            NameFull: Deodhar M
      – PersonEntity:
          Name:
            NameFull: Foot JS
      – PersonEntity:
          Name:
            NameFull: Zhou W
      – PersonEntity:
          Name:
            NameFull: Greco A
      – PersonEntity:
          Name:
            NameFull: Joshi A
      – PersonEntity:
          Name:
            NameFull: Rayner B
      – PersonEntity:
          Name:
            NameFull: Townsend S
      – PersonEntity:
          Name:
            NameFull: Buson A
      – PersonEntity:
          Name:
            NameFull: Jarolimek W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2019 Mar
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1582-4934
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of cellular and molecular medicine
              Type: main
ResultId 1